Previous experimental and in vivo data from our group suggested that the cytoskeleton regulatory protein hMena and its splice-variant deriving isoform, hMena11a, may couple ErbB family signalling to the actin cytoskeleton leading to cell proliferation in breast cancer [16]. Here, EGFR is linked to breast carcinoma.